Implantable Cardiac Pacemaker Market

Implantable Cardiac Pacemaker Market - Trends and
Opportunity Analysis, 2018-2026
Since the evolution of implantable cardiac pacemakers, cardiac pacing devices are extensively
used to treat bradycardia (delayed or absent activation of the entire ventricle) and Cardiac
Resynchronization Therapy (CRT). Implantable cardiac pacemakers are the small devices, which
are placed inside the chest or abdomen in order to control abnormal heart rhythms. Pacemakers
are also majorly used to treat arrhythmias: a problem with the rate of rhythm of heartbeat, in
which heart beats too fast and sometimes beats too slowly causing irregular rhythm.
Request PDF Brochure Of Research Report:
Several market players in emerging economies such as Asia and Middle East are offering
products with comparable performance levels to that of high-end implantable cardiac
pacemakers at affordable costs. This is mainly attributed to factors such as increasing
availability of skilled physicians and healthcare practitioners, lower costs incurred with medical
facilities, and combined efforts of government and domestic players to increase patient access.
Moreover, increasing prevalence of cardiovascular disease such as arrhythmia, atrial fibrillation,
long QT syndrome, bradycardia, and tachycardia coupled with adoption of sedentary and
unhealthy lifestyle are further expected to augment growth of implantable cardiac pacemaker
market over the forecast period
The global implantable cardiac pacemaker market was valued at US$ 4.7 billion in 2017 and is
expected to witness a CAGR of 7.1% over the forecast period (2018 – 2026).
Report includes chapters which deeply display the following deliverable about industry :
• Implantable Cardiac Pacemaker Market Research Objective and Assumption
• Implantable Cardiac Pacemaker Market Purview - Report Description, Executive Summary, and
Coherent Opportunity Map (COM)
• Implantable Cardiac Pacemaker Market Dynamics, Regulations, and Trends Analysis - Market
Dynamics, Regulatory Scenario, Industry Trend, Merger and Acquisitions, New system
Launch/Approvals, Value Chain Analysis, Porter’s Analysis, and PEST Analysis
• Global Implantable Cardiac Pacemaker Market, By Regions
• Implantable Cardiac Pacemaker Market Competition by Manufacturers including Production,
Share, Revenue, Average Price, Manufacturing Base Distribution, Sales Area and Product Type.
• Implantable Cardiac Pacemaker Market Manufacturers Profiles/Analysis including Company
Basic Information, Manufacturing Base and Its Competitors.
• Implantable Cardiac Pacemaker Market Manufacturing Cost Analysis including Key Raw
Materials and Key Suppliers of Raw Materials.
• Industrial Chain, Sourcing Strategy and Downstream Buyers including Upstream Raw Materials
Sourcing and Downstream Buyers
• Marketing Strategy Analysis, Distributors/Traders including Marketing Channel, Market
Positioning and Distributors/Traders List.
• Market Effect Factors Analysis including Technology Progress/Risk, Consumer Needs/Customer
Preference Change and Economic/Political Environmental Change.
• Implantable Cardiac Pacemaker Market Forecast including Production, Consumption, Import
and Export Forecast by Type, Applications and Region.
• Research Findings and Conclusion
Introduction of Advanced Pacemaker Technologies is Expected to Drive Growth of the
Implantable Cardiac Pacemaker Market
Adoption of advanced technologies in cardiac pacemakers such as MRI safe-pacemakers,
pacemakers with improved battery life, delay the progression of persistent Atrial Fibrillation
(AF) in patients suffering from bradycardia and wireless automated technologies. This
advancements are gaining significant traction of various market players of implantable cardiac
pacemakers with affordable costs, which in turn are expected to drive growth of implantable
cardiac pacemakers market. For instance, in February 2017, Abbott received the Food and Drug
Administration (FDA) approval for its MR-conditional labeling for both of its products i.e.
Assurity MRI pacemaker and the Tendril MRI pacing lead. Furthermore, introduction of advance
technology such as wireless and automated pacemaker monitoring pacemakers are gaining
significant traction among healthcare providers.
Increasing Prevalence of Cardiovascular Disease is Expected to Drive Growth of Implantable
Cardiac Pacemaker Market
Increasing incidence of cardiovascular diseases is expected to boost growth of the implantable
cardiac pacemakers market over the forecast period. According to the Centers for Disease
Control and Prevention (CDC), August 2017 data findings, Atrial Fibrillation (AFib or AF) is
most common type of heart arrhythmia, which affected an estimated 2.7 to 6.1 million people
in the U.S. and the number is expected to increase in near future. Furthermore, Atrial
Fibrillation cases increase with age and it is more prominent in men than women. Moreover,
increasing number of geriatric population across the various regions worldwide along with high
prevalence of heart disease is expected to propel demand for implantable cardiac pacemakers in
the near future.
Browse Complete Report For More Information @
Market Dynamics
Market players are engaged in developing novel pacemakers with ability to control the
abnormal heart rhythm, monitor and record patient’s heart's electrical activity, blood
temperature, and breathing rate. Technological advances in the field of implantable cardiac
pacemakers along with increasing prevalence of cardiovascular disease is projected to drive the
growth of implantable cardiac pacemaker market over the forecast period.
Some of the key players operating in implantable cardiac pacemaker market include Medtronic
plc, BIOTRONIK, Inc., Boston Scientific Corporation, St. Jude Medical, Vitatron Holding B.V.,
Shree Pacetronix Ltd., MEDICO S.p.A., Lepu Medical Technology Co Ltd., LivaNova PLC, and
Qinming Medical.
About Coherent Market Insights
Coherent Market Insights is a prominent market research and consulting firm offering actionready syndicated research reports, custom market analysis, consulting services, and competitive
analysis through various recommendations related to emerging market trends, technologies, and
potential absolute dollar opportunity.
Contact Us
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: [email protected]

Implantable cardiac pacemaker is a small device implanted in the chest or abdomen for the treatment of abnormal heart rhythms, arrhythmia, heart block, and atrial fibrillation.